Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive butorphanol dosing before microvascular decompression in hemifacial spasm
ChiCTR1900020821Phase 4Recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butorphanol in hemifacial spasm (HFS) (4 arms), sponsored by Liaoning Provincial People's Hospital. Primary endpoints: Heart rate, Systolic blood pressure and 6 more. Started Jan 2019; status: recruiting.
02
Drugs
butorphanol
03
Conditions
hemifacial spasm (HFS)
Beyond the preview
Go deeper on ChiCTR1900020821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020821.